SYNDAX PHARMACEUTICALS INC (SNDX) Stock Cash Flow
NASDAQ:SNDX - Nasdaq - US87164F1057 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -331.20M | -318.76M | -209.36M | -149.34M | 24.93M | |||
| Depreciation Amortization | 5.00K | 8.00K | 12.00K | 30.00K | 40.00K | |||
| Change In Working Capital | 12.31M | 13.27M | 31.86M | 1.66M | -9.60M | |||
| Interest Paid | N/A | 0.00 | 0.00 | 2.06M | 2.00M | |||
| Other non cash items | 32.37M | 30.58M | 16.89M | 13.97M | 13.76M | |||
| OPERATING CASH FLOW | -286.52M | -274.90M | -160.60M | -133.68M | 29.13M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | 0.00 | 0.00 | -130.00K | |||
| Other Investing Activity | -26.23M | -219.78M | 117.61M | -186.19M | -40.74M | |||
| INVESTING CASH FLOW | -26.23M | -219.78M | 117.61M | -186.19M | -40.87M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 0.00 | -21.00M | 0.00 | |||
| Stock Issued/Repurchased | 8.48M | 9.71M | 264.13M | 193.25M | 93.04M | |||
| Other Financing Activity | N/A | 343.65M | 0.00 | 0.00 | 25.42M | |||
| FINANCING CASH FLOW | 352.13M | 353.37M | 264.13M | 172.25M | 118.46M | |||
| CHANGE IN CASH | 39.38M | -141.31M | 221.14M | -147.62M | 106.72M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -286.52M | -274.90M | -160.60M | -133.68M | 29.13M | |||
| Capital Expenditure | N/A | N/A | 0.00 | 0.00 | -130.00K | |||
| FREE CASH FLOW | -286.52M | -274.90M | -160.60M | -133.68M | 29.00M | |||
All data in USD